Number and rate* of newly reported cases† of chronic Hepatitis B virus infection, by state or jurisdiction — United States, 2021
* Rates per 100,000 population.
† Reported confirmed cases. For case definition, see Chronic Hepatitis B.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
In the United States, chronic hepatitis B is one of the leading causes of cirrhosis, which is a major cause of liver cancer. This table displays the number and rates of newly reported chronic hepatitis B cases during 2021, by state or jurisdiction. In 2021, chronic hepatitis B was not a reportable condition in four states (Connecticut, Kentucky, Mississippi, and Texas), and cases were unavailable from seven states or jurisdictions (Alabama, Arkansas, California, District of Columbia, Hawaii, New Hampshire, and Rhode Island). Of note, cases of newly reported chronic hepatitis B do not represent all prevalent hepatitis B virus infections, which cannot be captured in the National Notifiable Diseases Surveillance System. The highest rate of newly reported chronic hepatitis B was in Oklahoma (12.0 cases per 100,000 population), whereas the lowest rate was in Kansas (0.4 cases per 100,000 population).
- Figure 2.1. Number of reported cases of acute hepatitis B virus infection and estimated infections — United States, 2014–2021
- Figure 2.2. Rates of reported acute hepatitis B virus infection, by state or jurisdiction — United States, 2020–2021
- Figure 2.3. Rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2021
- Figure 2.4. Rates of reported cases of acute hepatitis B virus infection, by age group — United States, 2006–2021
- Figure 2.5. Rates of reported cases of acute hepatitis B virus infection, by sex — United States, 2006–2021
- Figure 2.6. Rates of reported cases of acute hepatitis B virus infection, by race/ethnicity — United States, 2006–2021
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B virus infection — United States, 2021
- Figure 2.8. Rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2021
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2017–2021
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B virus infection, by demographic characteristics — United States, 2017–2021
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B virus infection — United States, 2021
- Table 2.4. Number of newly reported cases of perinatal hepatitis B virus infection, by state or jurisdiction — United States, 2021
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2021
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B virus infection, by demographic characteristics — United States, 2021
- Table 2.7. Numbers and rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2017–2021
- Table 2.8. Numbers and rates of deaths with hepatitis B virus infections listed as a cause of death among residents, by demographic characteristics — United States, 2017–2021